Sort
261,768 grants matching “gene therapy”
Immunopathogenesis of Fungal Infections
$2,116,544Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Pathophysiology and Treatment of Fanconi's Anemia
$2,116,459Markus Grompe · Oregon Health & Science University · P01 · FY2010 · HL
AAV Gene Therapy for Lipid Disorders
$2,116,284James M Wilson · University Of Pennsylvania · P01 · FY2015 · HL
Pro-inflammatory cytokine lowering anti-inflammatory drugs
$2,115,683Nigel H. Greig · National Institute On Aging · ZIA · FY2020 · AG
Gene Therapy for Sickle Cell Disease
$2,115,664St. Jude Children'S Research Hospital · P01 · FY2005 · HL
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$2,115,615Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
$2,115,286Kelan G Tantisira · University Of California, San Diego · R01 · FY2022 · HL
Improving the safety and efficacy of cell therapies
$2,115,190Malcolm K Brenner · Baylor College Of Medicine · U54 · FY2009 · HL
Mechanisms and Markers of Prostate Cancer Metastases
$2,114,342University Of Washington · P01 · FY2004 · CA
Microbial exploration for new antimicrobial discovery
$2,114,260Akintunde Emiola · National Institute Of Dental & Craniofacial Research · ZIA · FY2025 · DE
Inherited Ocular Diseases
$2,114,089James F. Hejtmancik · National Eye Institute · ZIA · FY2018 · EY
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
$2,113,516Steven Edward Lipshultz · Wayne State University · R01 · FY2014 · HL
Preclinical drug development in pancreatic cancer
$2,113,368Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Head and Neck Cancer SPORE
$2,112,973Robert L Ferris · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA
Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
$2,112,893Sean Ekins · Collaborations Pharmaceuticals, Inc. · SB1 · FY2025 · NS
Testing Optimal Gene Editor for an Alzheimer's CRISPR therapeutic.
$2,112,826Subhojit Roy · University Of California, San Diego · UF1 · FY2023 · NS
Multiscale Analysis of Immune Responses
$2,112,763Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Diverse Strategies to Correct the Dystrophin Gene Using Vascular Delivery (U54)
$2,112,675Jerry Mendell · Research Inst Nationwide Children'S Hosp · U54 · FY2009 · NS
MOLECULAR PATHWAYS FOR HYPERTROPHY AND CARDIOMYOPATHY
$2,112,637University Of California San Diego · P01 · FY2004 · HL
UCLA SPORE in Brain Cancer
$2,112,473Linda M Liau · University Of California Los Angeles · P50 · FY2024 · CA
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma
$2,112,284Lisa Rimsza · Mayo Clinic Arizona · P01 · FY2020 · CA
A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial
$2,111,999Sachin Wani · University Of Colorado Denver · U01 · FY2024 · DK
Pathophysiology and Treatment of Fanconi's Anemia
$2,111,574Markus Grompe · Oregon Health & Science University · P01 · FY2011 · HL
FUNCTIONAL GENOMICS OF THE BETA-CELL
$2,111,099Klaus H. Kaestner · University Of Pennsylvania · U01 · FY2006 · DK
Radiation-induced molecular targets
$2,111,063Norman Coleman · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA